GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biostar Pharmaceuticals Inc (OTCPK:BSPM) » Definitions » Gross Margin %

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Gross Margin % : 0.00% (As of Sep. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Biostar Pharmaceuticals Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Biostar Pharmaceuticals's Gross Profit for the three months ended in Sep. 2017 was $0.00 Mil. Biostar Pharmaceuticals's Revenue for the three months ended in Sep. 2017 was $0.00 Mil. Therefore, Biostar Pharmaceuticals's Gross Margin % for the quarter that ended in Sep. 2017 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Biostar Pharmaceuticals's Gross Margin % or its related term are showing as below:


BSPM's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 46.8
* Ranked among companies with meaningful Gross Margin % only.

Biostar Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Sep. 2017 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Biostar Pharmaceuticals was 0.00% per year.


Biostar Pharmaceuticals Gross Margin % Historical Data

The historical data trend for Biostar Pharmaceuticals's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostar Pharmaceuticals Gross Margin % Chart

Biostar Pharmaceuticals Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.53 48.71 49.30 40.93 38.38

Biostar Pharmaceuticals Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.75 -11.64 - - -

Competitive Comparison of Biostar Pharmaceuticals's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Biostar Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biostar Pharmaceuticals's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biostar Pharmaceuticals's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Biostar Pharmaceuticals's Gross Margin % falls into.



Biostar Pharmaceuticals Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Biostar Pharmaceuticals's Gross Margin for the fiscal year that ended in Dec. 2016 is calculated as

Gross Margin % (A: Dec. 2016 )=Gross Profit (A: Dec. 2016 ) / Revenue (A: Dec. 2016 )
=0.9 / 2.384
=(Revenue - Cost of Goods Sold) / Revenue
=(2.384 - 1.469) / 2.384
=38.38 %

Biostar Pharmaceuticals's Gross Margin for the quarter that ended in Sep. 2017 is calculated as


Gross Margin % (Q: Sep. 2017 )=Gross Profit (Q: Sep. 2017 ) / Revenue (Q: Sep. 2017 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Biostar Pharmaceuticals  (OTCPK:BSPM) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Biostar Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Sep. 2017 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Biostar Pharmaceuticals Gross Margin % Related Terms

Thank you for viewing the detailed overview of Biostar Pharmaceuticals's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biostar Pharmaceuticals (Biostar Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
No. 588 Shiji Xi Avenue, Shaanxi Province, Xianyang, CHN, 712046
Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Headlines